Name: Avelumab Biosimilar - Research Grade, Low Endotoxin
Price: 560.00 USD

- Overview
  - Specificity: Detects human PDL-1. This non-therapeutic antibody uses the same sequence as the therapeutic antibody Avelumab.
    Purification method: This monoclonal antibody was purified using multi-step affinity chromatography methods such as Protein A or G depending on the species and isotype.
    Isotype Control: Bulk Human IgG1 Isotype Control (IB1) [ICH2254]
    Endotoxin: ≤ 0.75 EU/mg as determined by the LAL method
    
    Please contact us at for specific academic pricing.
    
    Background
    
    Avelumab biosimilar is a programmed death ligand-1 (PD-L1) blocking antibody. Avelumab is a human IgG1 lambda monoclonal antibody that has a molecular weight of approximately 147 kDa.
- Properties
  - Host
    
    humanized
    
    Isotype
    
    IgG1 lambda
    
    Reactivity
    
    human
    
    Purification
    
    >95% by SDS-PAGE and HPLC
    
    Formulation
    
    Phosphate buffered saline (PBS) pH 7.2,with no carrier protein, potassium or preservatives added. BSA and Azide free.
    
    Storage
    
    Stable for at least one week when stored sterile at 2-8°C. For long term storage aseptically aliquot in working volumes without diluting and store at –80°C. Avoid Repeated Freeze Thaw Cycles.
    
    Molecular Weight
    
    1.0 - 5.0 mg/ml
    
    Antigen
    
    (Gene ID:Programmed cell death 1 ligand 1, Cd274, PDCD1 ligand 1, Programmed death ligand 1, B7 homolog 1, B7-H1, B7h1, Pdcd1l1, Pdcd1lg1, Pdl1, PDL-1)
    
    * Products are for research use only. Not for use in diagnostic or therapeutic procedures.

Avelumab Biosimilar - Research Grade, Low Endotoxin

Avelumab Biosimilar - Research Grade, Low Endotoxin

Background

We Also Recommend

Atezolizumab Biosimilar - Research Grade, Low Endotoxin

Daratumumab Biosimilar - Research Grade, Low Endotoxin

Denosumab Biosimilar - Research Grade, Low Endotoxin